Get the Stockscreener App
1.80
1.12%
0.02
Conduit Pharmaceuticals Inc stock is traded at $1.80, with a volume of 96,413.
It is up +1.12% in the last 24 hours and down -35.48% over the past month.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
See More
Previous Close:
$1.78
Open:
$1.81
24h Volume:
96,413
Relative Volume:
0.30
Market Cap:
$1.42M
Revenue:
-
Net Income/Loss:
$-4.21M
P/E Ratio:
-32.85
EPS:
-0.0548
Net Cash Flow:
-
1W Performance:
-10.00%
1M Performance:
-35.48%
6M Performance:
-95.16%
1Y Performance:
-99.41%
1-Day Range:
$1.70
$1.83
1-Week Range:
$1.70
$2.0999
52-Week Range:
$1.70
$622.50
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Name
Conduit Pharmaceuticals Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Conduit Pharmaceuticals Inc
|
1.80 | 4.28M | 0 | -4.21M | 0 | -0.0548 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Conduit Pharmaceuticals Inc Stock (CDT) Latest News
What catalysts could drive Conduit Pharmaceuticals Inc. stock higher in 2025Retirement Planning Target Finder Backed By Experts - jammulinksnews.com
What are Conduit Pharmaceuticals Inc. company’s key revenue driversRetirement Planning Tips With Low Risk - jammulinksnews.com
How does Conduit Pharmaceuticals Inc. generate profit in a changing economyFinancial News Tracker With High Returns - jammulinksnews.com
What makes Conduit Pharmaceuticals Inc. Equity Warrant stock price move sharplyEarnings Report Recommendation To Watch Now - jammulinksnews.com
How many analysts rate Conduit Pharmaceuticals Inc. as a “Buy”Financial News Guidance For Beginners - jammulinksnews.com
Is Conduit Pharmaceuticals Inc. Equity Warrant a growth stock or a value stockBreakout Stocks Updates With Proven Results - jammulinksnews.com
Conduit Pharmaceuticals settles debt, converts senior note - MSN
Why Conduit Pharmaceuticals Inc. Equity Warrant stock attracts strong analyst attentionCommunity Verified Stock Suggestions Drive Volume - beatles.ru
Conduit Pharmaceuticals Inc. Volume Confirms Breakout — Analysts BullishExit Ready Momentum Stock Watchlist Expanded - beatles.ru
Will Conduit Pharmaceuticals Inc. Sustain Its Chart BreakoutReal-Time Trade Insights Spark Market Reactions - metal.it
What does recent volatility data suggest for Conduit Pharmaceuticals Inc.Buy Alerts With Low Risk Confirmation Noted - metal.it
Traders Consider Averaging Down in Conduit Pharmaceuticals Inc. Equity WarrantNews Based Entry Opportunity Alerts Detected - metal.it
Watch for Trend Continuation in Conduit Pharmaceuticals Inc. Next WeekEntry and Exit Strategy Optimizer Tool Tested - metal.it
Is it the right time to buy Conduit Pharmaceuticals Inc. Equity Warrant stockSwing Trade Target Finder With Low Risk - jammulinksnews.com
Conduit Pharmaceuticals Inc. Stages Intraday Comeback — Trend ChangeStep-by-Step Trade Signal Implementation Guide Ready - metal.it
Live Scanner Shows Breakout on Conduit Pharmaceuticals Inc.High Yield Stock Screening Results Explained - metal.it
Published on: 2025-07-28 19:25:21 - beatles.ru
Does Conduit Pharmaceuticals Inc. Equity Warrant stock perform well during market downturnsBuild a diversified portfolio for stability - jammulinksnews.com
Does Conduit Pharmaceuticals Inc. stock perform well during market downturnsSuperior trading gains - jammulinksnews.com
Why is Conduit Pharmaceuticals Inc. stock attracting strong analyst attentionRecord-setting profit potential - jammulinksnews.com
How does Conduit Pharmaceuticals Inc. compare to its industry peersCapitalize on market momentum for maximum gains - jammulinksnews.com
What catalysts could drive Conduit Pharmaceuticals Inc. Equity Warrant stock higher in 2025Financial News Report That Work - jammulinksnews.com
Should I hold or sell Conduit Pharmaceuticals Inc. stock in 2025Market Forecast Data Feed Backed By Experts - jammulinksnews.com
What is the risk reward ratio of investing in Conduit Pharmaceuticals Inc. stockTriple-digit returns - jammulinksnews.com
What is Conduit Pharmaceuticals Inc. Equity Warrant company’s growth strategyConsistently superior profits - jammulinksnews.com
Is Conduit Pharmaceuticals Inc. stock overvalued or undervaluedGet professional guidance for market timing - jammulinksnews.com
What are Conduit Pharmaceuticals Inc. Equity Warrant company’s key revenue driversSmart Portfolio Signals To Watch Now - jammulinksnews.com
What institutional investors are buying Conduit Pharmaceuticals Inc. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
What is the dividend policy of Conduit Pharmaceuticals Inc. stockExplosive market performance - jammulinksnews.com
How volatile is Conduit Pharmaceuticals Inc. Equity Warrant stock compared to the marketUnlock rapid growth potential in your portfolio - jammulinksnews.com
How does Conduit Pharmaceuticals Inc. Equity Warrant compare to its industry peersFree Market Volatility Navigation Tips - jammulinksnews.com
When is Conduit Pharmaceuticals Inc. stock expected to show significant growthFree Capital Growth Strategies - jammulinksnews.com
What are analysts’ price targets for Conduit Pharmaceuticals Inc. in the next 12 monthsFree High-Return Strategy Alerts - jammulinksnews.com
Will Conduit Pharmaceuticals Inc. Equity Warrant Stock Benefit from AI and Green Energy TrendsTop Rated Trade Entries - metal.it
Published on: 2025-07-27 20:33:09 - jammulinksnews.com
Published on: 2025-07-27 20:22:13 - jammulinksnews.com
Intrinsic Value of Conduit Pharmaceuticals Inc. Stock: Is It Undervalued or OvervaluedTop Gaining Low Risk Assets - Newser
How Conduit Pharmaceuticals Inc. Equity Warrant stock performs during market volatilityAnalyst Grade Signals - Newser
What analysts say about Conduit Pharmaceuticals Inc. stockFree Consultation - PrintWeekIndia
Conduit Pharmaceuticals Inc. Stock Analysis and ForecastRapid capital growth - PrintWeekIndia
Why Conduit Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
Why Conduit Pharmaceuticals Inc. stock is on top investor watchlistsSuperior trading gains - jammulinksnews.com
Conduit Pharmaceuticals Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):